Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus
- Autores
- Gironacci, Mariela Mercedes; Vatta, Marcelo Sergio; Rodríguez Fermepin, Martin; Fernandez, Belisario Enrique; Peña, Clara
- Año de publicación
- 2000
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Angiotensin (Ang)-(1-7) elicits a facilitatory presynaptic effect on peripheral noradrenergic neurotransmission, and because biological responses to the heptapeptide on occasion are tissue specific, the present investigation was undertaken to study its action on noradrenergic neurotransmission at the central level. In rat hypothalamus labeled with [3H]-norepinephrine, 100 to 600 nmol/L Ang-(1-7) diminished norepinephrine released by 25 mmol/L KCl. This effect was blocked by the selective angiotensin type 2 receptor antagonist PD 123319 (1 μmol/L) and by the specific Ang-(1-7) receptor antagonist [D-Ala7]Ang-(1-7) (1 μmol/L) but not by losartan (10 nmol/L to μmol/L), a selective angiotensin type 1 receptor antagonist. The inhibitory effect on noradrenergic neurotransmission caused by Ang-(1-7) was prevented by 10 μmol/L N(ω)-nitro-L-arginine methylester, an inhibitor of nitric oxide synthase activity, and was restored by 100 μmol/L L-arginine, precursor of nitric oxide synthesis. Methylene blue (10 μmol/L), an inhibitor of guanylate cyclase considered as the target of nitric oxide action, as well as Hoe 140 (10 μmol/L), a bradykinin B2- receptor antagonist, prevented the inhibitory effect of the heptapeptide on neuronal norepinephrine release, whereas no modification was observed in the presence of 0.1 to 10μmol/L indomethacin, a cyclooxygenase inhibitor. Our results indicate that Ang-(1-7) has a tissue-specific neuromodulatory effect on noradrenergic neurotransmission, being inhibitory at the central nervous system by a nitric oxide-dependent mechanism that involves angiotensin type 2 receptors and local bradykinin production.
Fil: Gironacci, Mariela Mercedes. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Físico-Química Biológicas "Prof. Alejandro C. Paladini". Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Físico-Química Biológicas; Argentina
Fil: Vatta, Marcelo Sergio. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Metabolismo del Fármaco. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Metabolismo del Fármaco; Argentina
Fil: Rodríguez Fermepin, Martin. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Ciencias Biológicas. Cátedra de Fisiopatología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina
Fil: Fernandez, Belisario Enrique. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Ciencias Biológicas. Cátedra de Fisiopatología; Argentina
Fil: Peña, Clara. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Físico-Química Biológicas "Prof. Alejandro C. Paladini". Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Físico-Química Biológicas; Argentina - Materia
-
Angiotensin
Angiotensin Antagonist
Bradykinin
Nitric Oxide
Norepinephrine
Prostaglandins - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/40455
Ver los metadatos del registro completo
id |
CONICETDig_60de4787df4d3fb5c46b9ed956d50f36 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/40455 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamusGironacci, Mariela MercedesVatta, Marcelo SergioRodríguez Fermepin, MartinFernandez, Belisario EnriquePeña, ClaraAngiotensinAngiotensin AntagonistBradykininNitric OxideNorepinephrineProstaglandinshttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Angiotensin (Ang)-(1-7) elicits a facilitatory presynaptic effect on peripheral noradrenergic neurotransmission, and because biological responses to the heptapeptide on occasion are tissue specific, the present investigation was undertaken to study its action on noradrenergic neurotransmission at the central level. In rat hypothalamus labeled with [3H]-norepinephrine, 100 to 600 nmol/L Ang-(1-7) diminished norepinephrine released by 25 mmol/L KCl. This effect was blocked by the selective angiotensin type 2 receptor antagonist PD 123319 (1 μmol/L) and by the specific Ang-(1-7) receptor antagonist [D-Ala7]Ang-(1-7) (1 μmol/L) but not by losartan (10 nmol/L to μmol/L), a selective angiotensin type 1 receptor antagonist. The inhibitory effect on noradrenergic neurotransmission caused by Ang-(1-7) was prevented by 10 μmol/L N(ω)-nitro-L-arginine methylester, an inhibitor of nitric oxide synthase activity, and was restored by 100 μmol/L L-arginine, precursor of nitric oxide synthesis. Methylene blue (10 μmol/L), an inhibitor of guanylate cyclase considered as the target of nitric oxide action, as well as Hoe 140 (10 μmol/L), a bradykinin B2- receptor antagonist, prevented the inhibitory effect of the heptapeptide on neuronal norepinephrine release, whereas no modification was observed in the presence of 0.1 to 10μmol/L indomethacin, a cyclooxygenase inhibitor. Our results indicate that Ang-(1-7) has a tissue-specific neuromodulatory effect on noradrenergic neurotransmission, being inhibitory at the central nervous system by a nitric oxide-dependent mechanism that involves angiotensin type 2 receptors and local bradykinin production.Fil: Gironacci, Mariela Mercedes. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Físico-Química Biológicas "Prof. Alejandro C. Paladini". Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Físico-Química Biológicas; ArgentinaFil: Vatta, Marcelo Sergio. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Metabolismo del Fármaco. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Metabolismo del Fármaco; ArgentinaFil: Rodríguez Fermepin, Martin. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Ciencias Biológicas. Cátedra de Fisiopatología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; ArgentinaFil: Fernandez, Belisario Enrique. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Ciencias Biológicas. Cátedra de Fisiopatología; ArgentinaFil: Peña, Clara. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Físico-Química Biológicas "Prof. Alejandro C. Paladini". Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Físico-Química Biológicas; ArgentinaLippincott Williams2000-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/40455Gironacci, Mariela Mercedes; Vatta, Marcelo Sergio; Rodríguez Fermepin, Martin; Fernandez, Belisario Enrique; Peña, Clara; Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus; Lippincott Williams; Hypertension; 35; 6; 6-2000; 1248-12520194-911XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://hyper.ahajournals.org/content/35/6/1248.longinfo:eu-repo/semantics/altIdentifier/doi/10.1161/01.HYP.35.6.1248info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:46:01Zoai:ri.conicet.gov.ar:11336/40455instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:46:01.927CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus |
title |
Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus |
spellingShingle |
Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus Gironacci, Mariela Mercedes Angiotensin Angiotensin Antagonist Bradykinin Nitric Oxide Norepinephrine Prostaglandins |
title_short |
Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus |
title_full |
Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus |
title_fullStr |
Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus |
title_full_unstemmed |
Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus |
title_sort |
Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus |
dc.creator.none.fl_str_mv |
Gironacci, Mariela Mercedes Vatta, Marcelo Sergio Rodríguez Fermepin, Martin Fernandez, Belisario Enrique Peña, Clara |
author |
Gironacci, Mariela Mercedes |
author_facet |
Gironacci, Mariela Mercedes Vatta, Marcelo Sergio Rodríguez Fermepin, Martin Fernandez, Belisario Enrique Peña, Clara |
author_role |
author |
author2 |
Vatta, Marcelo Sergio Rodríguez Fermepin, Martin Fernandez, Belisario Enrique Peña, Clara |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
Angiotensin Angiotensin Antagonist Bradykinin Nitric Oxide Norepinephrine Prostaglandins |
topic |
Angiotensin Angiotensin Antagonist Bradykinin Nitric Oxide Norepinephrine Prostaglandins |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Angiotensin (Ang)-(1-7) elicits a facilitatory presynaptic effect on peripheral noradrenergic neurotransmission, and because biological responses to the heptapeptide on occasion are tissue specific, the present investigation was undertaken to study its action on noradrenergic neurotransmission at the central level. In rat hypothalamus labeled with [3H]-norepinephrine, 100 to 600 nmol/L Ang-(1-7) diminished norepinephrine released by 25 mmol/L KCl. This effect was blocked by the selective angiotensin type 2 receptor antagonist PD 123319 (1 μmol/L) and by the specific Ang-(1-7) receptor antagonist [D-Ala7]Ang-(1-7) (1 μmol/L) but not by losartan (10 nmol/L to μmol/L), a selective angiotensin type 1 receptor antagonist. The inhibitory effect on noradrenergic neurotransmission caused by Ang-(1-7) was prevented by 10 μmol/L N(ω)-nitro-L-arginine methylester, an inhibitor of nitric oxide synthase activity, and was restored by 100 μmol/L L-arginine, precursor of nitric oxide synthesis. Methylene blue (10 μmol/L), an inhibitor of guanylate cyclase considered as the target of nitric oxide action, as well as Hoe 140 (10 μmol/L), a bradykinin B2- receptor antagonist, prevented the inhibitory effect of the heptapeptide on neuronal norepinephrine release, whereas no modification was observed in the presence of 0.1 to 10μmol/L indomethacin, a cyclooxygenase inhibitor. Our results indicate that Ang-(1-7) has a tissue-specific neuromodulatory effect on noradrenergic neurotransmission, being inhibitory at the central nervous system by a nitric oxide-dependent mechanism that involves angiotensin type 2 receptors and local bradykinin production. Fil: Gironacci, Mariela Mercedes. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Físico-Química Biológicas "Prof. Alejandro C. Paladini". Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Físico-Química Biológicas; Argentina Fil: Vatta, Marcelo Sergio. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Metabolismo del Fármaco. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Metabolismo del Fármaco; Argentina Fil: Rodríguez Fermepin, Martin. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Ciencias Biológicas. Cátedra de Fisiopatología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina Fil: Fernandez, Belisario Enrique. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Ciencias Biológicas. Cátedra de Fisiopatología; Argentina Fil: Peña, Clara. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Química y Físico-Química Biológicas "Prof. Alejandro C. Paladini". Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Química y Físico-Química Biológicas; Argentina |
description |
Angiotensin (Ang)-(1-7) elicits a facilitatory presynaptic effect on peripheral noradrenergic neurotransmission, and because biological responses to the heptapeptide on occasion are tissue specific, the present investigation was undertaken to study its action on noradrenergic neurotransmission at the central level. In rat hypothalamus labeled with [3H]-norepinephrine, 100 to 600 nmol/L Ang-(1-7) diminished norepinephrine released by 25 mmol/L KCl. This effect was blocked by the selective angiotensin type 2 receptor antagonist PD 123319 (1 μmol/L) and by the specific Ang-(1-7) receptor antagonist [D-Ala7]Ang-(1-7) (1 μmol/L) but not by losartan (10 nmol/L to μmol/L), a selective angiotensin type 1 receptor antagonist. The inhibitory effect on noradrenergic neurotransmission caused by Ang-(1-7) was prevented by 10 μmol/L N(ω)-nitro-L-arginine methylester, an inhibitor of nitric oxide synthase activity, and was restored by 100 μmol/L L-arginine, precursor of nitric oxide synthesis. Methylene blue (10 μmol/L), an inhibitor of guanylate cyclase considered as the target of nitric oxide action, as well as Hoe 140 (10 μmol/L), a bradykinin B2- receptor antagonist, prevented the inhibitory effect of the heptapeptide on neuronal norepinephrine release, whereas no modification was observed in the presence of 0.1 to 10μmol/L indomethacin, a cyclooxygenase inhibitor. Our results indicate that Ang-(1-7) has a tissue-specific neuromodulatory effect on noradrenergic neurotransmission, being inhibitory at the central nervous system by a nitric oxide-dependent mechanism that involves angiotensin type 2 receptors and local bradykinin production. |
publishDate |
2000 |
dc.date.none.fl_str_mv |
2000-06 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/40455 Gironacci, Mariela Mercedes; Vatta, Marcelo Sergio; Rodríguez Fermepin, Martin; Fernandez, Belisario Enrique; Peña, Clara; Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus; Lippincott Williams; Hypertension; 35; 6; 6-2000; 1248-1252 0194-911X CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/40455 |
identifier_str_mv |
Gironacci, Mariela Mercedes; Vatta, Marcelo Sergio; Rodríguez Fermepin, Martin; Fernandez, Belisario Enrique; Peña, Clara; Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus; Lippincott Williams; Hypertension; 35; 6; 6-2000; 1248-1252 0194-911X CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://hyper.ahajournals.org/content/35/6/1248.long info:eu-repo/semantics/altIdentifier/doi/10.1161/01.HYP.35.6.1248 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Lippincott Williams |
publisher.none.fl_str_mv |
Lippincott Williams |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842268769033912320 |
score |
13.13397 |